Epidemiology, Pathophysiology, & Management of Hyponatremic Encephalopathy
Am J Med 102:67-77, Fraser,C.L.,et al, 1997
Long-Term Effects of Tetrabenazine in Hyperkinetic Movement Disorders
Neurol 48:358-362, Jankovic,J.&Beach,J., 1997
Withdrawing Intensive Life-Sustaining Treatment-Recommendations for Compassionate Clin Mgmt
NEJM 336:652-657, Brody,H.,et al, 1997
Drug Treatment of Alzheimer's Disease, Raise Clinical and Ethical Problems
BMJ 314:693-694, Kelley,C.A.,et al, 1997
Risk of Alzheimer's Disease and Duration of NSAID Use
Neurol 48:626-632, Stewart,W.F.,et al, 1997
Botulinum Toxin Treatment of Muscle Cramps, A Clinical & Neurophysiological Study
Ann Neurol 41:181-186, Bertolasi,L.,et al, 1997
Stroke Associated with Cardiac Surgery, Determinants, Timing, & Stroke Subtypes
Arch Neurol 54:83-87, Libman,R.B.,et al, 1997
HIV-1 Protease Inhibitors
JAMA 227:145-149, Deeks,S.J.,et al, 1997
Local Thrombolytic Therapy in Deep Cerebral Venous Thrombosis
Neurol 48:1613-1619, Smith,A.G.,et al, 1997
Endovascular Thrombolysis in Deep Cerebral Venous Thrombosis
AJNR 18:502-506, Spearman,M.P.,et al, 1997
Direct Endovascular Thrombolytic Therapy for Dural Sinus Thrombosis:Infusion of Alteplase
AJNR 18:639-645, Kim,S.Y.&Suh,J.H., 1997
Limb-Shaking Carotid Transient Ischemic Attacks Successfully Treated with Modification of the Antihypertensive Regimen
Arch Neurol 54:904-905, Leira,E.C.,et al, 1997
A 36-Year-Old Woman Recuperating From a Stroke
JAMA 277:1970-1976, Alexander,M., 1997
Collaborative Systematic Rev of Random Trials of Inpt (Stroke Unit) Care After Stroke
Stroke Unit Trialists'Collab, BMJ 314:1151-11591997., , 1997
Regional Performance of Carotid Endarterectomy, Appropriateness, Outcomes and Risk Factors for Complications
Stroke 28:891-898, 8891997., Wong,J.H.,et al, 1997
Endarterectomy for Asymptomatic Internal Carotid Artery Stenosis
Neurol 48:1481-1490, Lanska,D.J.&Kryscio,R.J., 1997
Transcranial Doppler Monitoring and Causes of Stroke from Carotid Endarterectomy
Stroke 28:685-691, Spencer,M.P., 1997
Complication Rates for Carotid Endarterectomy
Stroke 28:889-890, Goldstein,L.B.,et al, 1997
Comparison of Carotid Endarterectomy Outcomes from Ransomized Trials & Medicare Administrative Databases
Arch Neurol 54:826-832, Stukenborg,G.J., 1997
Cysticercosis, Clinical Classification Based on Imaging Studies
Arch Int Med 157:1991-1997, Salgado,P.,et al, 1997
Alternating Amaurosis Fugax and Temporal Arteritis
Am J Ophthalmol 123:850-851, Finelli,P.F., 1997
Polymyalgia Rheumatica and Temporal Arteritis:Diagnosis and Management
BMJ 314:1329-1332, Swannell,A.J., 1997
Clinical Characteristics & Mgt of Acute Stroke in Pts with Atrial Fib Admitted to US Univ Hosp
Neurol 48:1598-1604, Albers,G.W.,et al, 1997
Does Paroxysmal Atrial Fibrillation Confer a Paroxysmal Thromboembolic Risk
Lancet 349:1565-1566, Lip,G.Y.H., 1997
Brain SPECT with HMPAO & Safety of Thrombolytic Therapy in Acute Ischemic Stroke
Stroke 28:1830-1834, Alexandrov,A.V.,et al, 1997
Intravenous Thrombolysis for Acute Stroke
Neurol 49:14-29, Lyden,P.D.,et al, 1997
Systematic Review of Evidence on Thrombolytic Therapy for Acute Ischaemic Stroke
Lancet 350:607-614, Wardlaw,J.M.,et al, 1997
A Systems Approach to Immediate Evaluation and Management of Hyperacute Stroke
NINDS Stroke Study Group, Stroke 28:1530-15401997., , 1997
CAST:Random Placebo-Controlled Trial of Early Aspirin Use in 20000 Pts with Acute Ischaemic Stroke
CAST Collab Grp, Lancet 349:1641-16491997., , 1997
Intl Stroke Trial:Random Trial of ASA
Subcut Heparin, Both, or Neither Among 19435 Pts with Ischaemic Stroke, IST Collab Grp, Lancet 349:1, 69-11997., 1997
Carotid Occlusive Disease and Stroke Risk in Coronary Artery Bypass Graft Surgery
Neurol 49:678-686, Dashe,J.F.,et al, 1997
Severe Pathological Crying After Left Anterior Choroidal Artery Infarct
Stroke 28:1464-1466, Derex,L.,et al, 1997
The Risks and Benefits of Carotid Endarterectomy in Patients with Near Occlusion of the Carotid Artery
Neurol 48:911-915, Morgenstern,L.B.,et al, 1997
Stroke Patients'Knowledge of Stroke
Stroke 28:912-915, Williams,L.S.,et al, 1997
Percutaneous Transluminal Angioplasty for Total Occlusion of Middle Cerebral Arteries
Neuroradiology 39:71-74, Mori,T.,et al, 1997
Primary Care Physician-Reported Secondary and Tertiary Stroke Prevention Practices
Stroke 28:746-751, Goldstein,L.B.,et al, 1997
Treatment of Multiple Cerebral Emboli from an Ulcerated, Thrombogenic Ascending Aorta with Aortectomy and Graft Replacement
Neurol 49:621-622, Belden,J.R.,et al, 1997
Stenting for Carotid Stenosis? [Letter]
NEJM 337:427-428, , 1997
Characterizing the Target of Acute Stroke Therapy
Stroke 28:866-872, Fisher,M., 1997
Prognosis of Stroke Patients Requiring Mechanical Ventilation in a Neurological Critical Care Unit
Stroke 28:711-715, Steiner,T.,et al, 1997
Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy Men
NEJM 336:973-979, 1014-10161997., Ridker,P.M.,et al, 1997
Management of Anticoagulation Before and AFter Elective Surgery
NEJM 336:1506-1511, Kearon,C.&Hirsh,J., 1997
Influence of Cholesterol on Survival After Stroke:Retrospective Study
BMJ 314:1584-1588, Dyker,A.G.,et al, 1997
Practice Guidelines for the Use of Imaging in Transient Ischemic Attacks and Acute Stroke
Stroke 28:1480-1497, Culebras,A.,et al, 1997
Amelioration of Refractory Dysesthetic Limb Pain in Multiple Sclerosis by Gabapentin
Neurol 49:304-305, Samkoff,L.M.,et al, 1997
Interferon Beta Results in Immediate Reduction of Contrast-Enhanced MRI Lesions in MS Pts Followed by Weekly MRI
Neurol 48:1446-1448, Calabresi,P.A.,et al, 1997
Character of MRI Response to Trtm with Interferon Beta-1B:Enhancing MRI Lesion Freq as Prim Outcome Measure
Neurol 49:862-869, Stone,L.A.,et al, 1997
Impact of Interferon Beta-1A On Neurologic Disability in Relapsing Multiple Sclerosis
Neurol 49:358-363, Rudick,R.A.,et al, 1997
Quantitative Assessment of Sustained-Release 4-Aminopyridine for Symptomatic Treatment of Multiple Sclerosis
Neurol 48:817-821, Schwid,S.R.,et al, 1997
Glatiramer Acetate for Relapsing Multiple Sclerosis
The Medical Letter 39:61-62, , 1997